BNTC (Benitec Biopharma) E10: $-53.75 (As of Mar. 2026)


BNTC Benitec Biopharma Inc BNTC
34 GF Score
Price $13.00
View Full Analysis

What is Benitec Biopharma E10?

Benitec Biopharma BNTC -5.01% 34 E10 is $-53.75 as of Mar. 2026. GuruFocus rates BNTC with a GF Score™ of 34/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Benitec Biopharma's adjusted earnings per share data for the three months ended in Mar. 2026 was $-0.240. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-53.75 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-25), Benitec Biopharma's current stock price is $13.00. Benitec Biopharma's E10 for the quarter that ended in Mar. 2026 was $-53.75. Benitec Biopharma's Shiller PE Ratio of today is .


Benitec Biopharma  (NAS:BNTC) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Benitec Biopharma E10 Related Terms


Benitec Biopharma E10 Historical Data

* Premium members only.

The historical data trend for Benitec Biopharma's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Benitec Biopharma E10 Chart

Benitec Biopharma Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -95.02 -90.43

Benitec Biopharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -91.18 -90.43 -55.34 -53.49 -53.75

BNTC vs OABI, FBRX, LXEO: E10 Comparison

For the Biotechnology subindustry, Benitec Biopharma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Benitec Biopharma Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Benitec Biopharma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Benitec Biopharma's Shiller PE Ratio falls into.


BNTC
34GF Score
Benitec Biopharma Inc BNTC
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Benitec Biopharma E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Benitec Biopharma's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.24/330.2130*330.2130
=-0.240

Current CPI (Mar. 2026) = 330.2130.

Benitec Biopharma Quarterly Data

per share eps CPI Adj_EPS
201606 -8.834 241.018 -12.103
201609 15.559 241.428 21.281
201612 -4.605 241.432 -6.298
201703 -0.368 243.801 -0.498
201706 -2.907 244.955 -3.919
201709 -56.018 246.819 -74.945
201712 -3.325 246.524 -4.454
201803 -3.027 249.554 -4.005
201806 -42.800 251.989 -56.086
201809 0.000 252.439 0.000
201812 0.000 251.233 0.000
201903 0.000 254.202 0.000
201906 0.000 256.143 0.000
201909 -22.780 256.759 -29.297
201912 -34.000 256.974 -43.690
202003 -33.320 258.115 -42.627
202006 -46.580 257.797 -59.664
202009 -41.650 260.280 -52.841
202012 -12.920 260.474 -16.379
202103 -13.940 264.877 -17.379
202106 -8.328 271.696 -10.122
202109 -10.540 274.310 -12.688
202112 -10.030 278.802 -11.880
202203 -6.800 287.504 -7.810
202206 -10.510 296.311 -11.712
202209 -7.980 296.808 -8.878
202212 -3.340 296.797 -3.716
202303 -2.670 301.836 -2.921
202306 -2.650 305.109 -2.868
202309 -3.050 307.789 -3.272
202312 -2.640 306.746 -2.842
202403 -0.230 312.332 -0.243
202406 -0.110 314.175 -0.116
202409 -0.180 315.301 -0.189
202412 -0.260 315.605 -0.272
202503 -0.380 319.799 -0.392
202506 -0.210 322.561 -0.215
202509 -0.220 324.800 -0.224
202512 -0.260 324.054 -0.265
202603 -0.240 330.213 -0.240

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-53.75 mean?
Benitec Biopharma (BNTC) has a E10 of $-53.75 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Benitec Biopharma and its competitors.
Is Benitec Biopharma's E10 too high?
Benitec Biopharma's current E10 is $-53.75. Overall, Benitec Biopharma has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Benitec Biopharma's E10 compare to OABI and FBRX?
Benitec Biopharma's E10 of $-53.75 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Benitec Biopharma and its competitors. Benitec Biopharma's current E10 is $-53.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Benitec Biopharma stock overvalued right now?
Benitec Biopharma (BNTC) has a current E10 of $-53.75. The current E10 is $-53.75. Benitec Biopharma's overall GF Score™ is 34/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Benitec Biopharma (BNTC), the current E10 is $-53.75 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Benitec Biopharma Business Description

Address 3940 Trust Way, Hayward, CA, USA, 94545
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
34GF Score

Get the complete analysis for BNTC

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.00
Price